Release Date: 31/08/18 08:07 Summary: Full Year Financial Report and App 4E Price Sensitive: Yes Download Document 1.25MB Download
MSB Mesoblast resubmits US FDA application for approval of Ryoncil in children with graft vs host disease; shares dip -4%